Quantitative Structure-Activity Relationships of Natural-Product-Inspired, Aminoalkyl-Substituted 1-Benzopyrans as Novel Antiplasmodial Agents. 2021

Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
Institute of Pharmaceutical Biology and Phytochemistry (IPBP), University of Münster, PharmaCampus, Corrensstrasse 48, 48149 Münster, Germany.

On the basis of the finding that various aminoalkyl-substituted chromene and chromane derivatives possess strong and highly selective in vitro bioactivity against Plasmodium falciparum, the pathogen responsible for tropical malaria, we performed a structure-activity relationship study for such compounds. With structures and activity data of 52 congeneric compounds from our recent studies, we performed a three-dimensional quantitative structure-activity relationship (3D-QSAR) study using the comparative molecular field analysis (CoMFA) approach as implemented in the Open3DQSAR software. The resulting model displayed excellent internal and good external predictive power as well as good robustness. Besides insights into the molecular interactions and structural features influencing the antiplasmodial activity, this model now provides the possibility to predict the activity of further untested compounds to guide our further synthetic efforts to develop even more potent antiplasmodial chromenes/chromanes.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
May 2021, Journal of medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
November 2012, European journal of medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
May 2019, Bioorganic chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
December 2020, European journal of medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
November 1999, Journal of medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
December 1998, Journal of medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
September 2017, European journal of medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
February 2023, Molecules (Basel, Switzerland),
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
February 1998, Bioorganic & medicinal chemistry,
Friederike M Wunsch, and Bernhard Wünsch, and Freddy A Bernal, and Thomas J Schmidt
January 1991, Pharmaceutical research,
Copied contents to your clipboard!